Stem Cell files patents for production of human motor neurons and progenitors

By Elaine Rigoli

Tampa, Fla., April 28 - Stem Cell Innovations, Inc. has filed a patent application protecting the differentiation of its proprietary human pluripotent stem cells into neural progenitor cells and purified populations of motor neurons.

These cells will initially be used in the company's core drug discovery and toxicology platform, according to a news release.

The company said it is also exploring therapeutic applications of these cells.

These cells have potential in both drug discovery and cell therapies to treat diseases such as ALS, Parkinson's, Huntington's, multiple sclerosis and spinal cord injury, officials said.

Stem Cell is a cell biology company located in Scotch Plains, N.J.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.